SPRO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Spero Therapeutics (SPRO) Earnings Date & Reports

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SPRO is expected to report earnings to fall 30.26% to -26 cents per share on May 09

Spero Therapeutics SPRO Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.18

Q2'24

Beat

by $0.05

Q1'24

Missed

by $0.12

The last earnings report on March 27 showed earnings per share of -37 cents, missing the estimate of -36 cents. With 216.49K shares outstanding, the current market capitalization sits at 39.47M.

View a ticker or compare two or three

Compare

SPRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SPRO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

675 Massachusetts Avenue

Phone

+1 857 242-1600

Employees

Web

https://www.sperotherapeutics.com